Search Within

Elisa De Stanchina

  1. "Rebecca Caeser"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (2)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (7)
  2. Center for Molecular Imaging and Biotechnology (CMIB) (7)
  3. Department of Medicine (7)
  4. GSK Faculty (7)
  5. Sloan Kettering Institute Postdocs (7)
  6. Solid Tumor Oncology Division (7)

More Groups

People
  1. Charles Rudin (7)
  2. Rebecca Caeser (7)
  3. Nisargbhai Shah (6)
  4. Triparna Sen (6)
  5. Sam Tischfield (5)
  6. Shweta Chavan (4)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (2)
Publications
  1. Cancer Research (2)
  2. Cell Reports (1)
  3. Journal of Thoracic Oncology (1)
  4. Nature Communications (1)
  5. Science Advances (1)
  6. iScience (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Cell Press (2)
  3. Amer Assoc Advancement Science (1)
  4. Elsevier Inc. (1)
  5. Nature Publishing Group (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ATR inhibition activates cancer cell cGAS/STING-interferon signaling and promotes antitumor immunity in small-cell lung cancer
    Journal Article

    Taniguchi, H.; Chakraborty, S.; Takahashi, N.; Banerjee, A.; Caeser, R.; Zhan, Y. A.; Tischfield, S. E.; Chow, A.; Nguyen, E. M.; Villalonga, Á Q.; more...
    Science Advances (2024)

    Fulltext@MSK | Save
  • Combination therapy with MDM2 and MEK inhibitors is effective in patient-derived models of lung adenocarcinoma with concurrent oncogenic drivers and MDM2 amplification
    Journal Article

    Elkrief, A.; Odintsov, I.; Markov, V.; Caeser, R.; Sobczuk, P.; Tischfield, S. E.; Bhanot, U.; Vanderbilt, C. M.; Cheng, E. H.; Drilon, A.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • STAT3-driven MAPK activation represents a therapeutic vulnerability in ASCL1 high SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • WEE1 inhibition enhances the antitumor immune response to PD-L1 blockade by the concomitant activation of STING and STAT1 pathways in SCLC
    Journal Article

    Taniguchi, H.; Caeser, R.; Chavan, S. S.; Zhan, Y. A.; Chow, A.; Manoj, P.; Uddin, F.; Kitai, H.; Qu, R.; Hayatt, O.; more...
    Cell Reports (2022)

    Fulltext@MSK | Save
  • Genomic and transcriptomic analysis of a library of small cell lung cancer patient-derived xenografts
    Journal Article

    Caeser, R.; Egger, J. V.; Chavan, S.; Socci, N. D.; Byrne Jones, C.; Kombak, F. E.; Asher, M.; Roehrl, M. H.; Shah, N. S.; Allaj, V.; more...
    Nature Communications (2022)

    Fulltext@MSK | Save
  • MAPK pathway activation selectively inhibits ASCL1-driven small cell lung cancer
    Journal Article

    Caeser, R.; Hulton, C.; Costa, E.; Durani, V.; Little, M.; Chen, X.; Tischfield, S. E.; Asher, M.; Kombak, F. E.; Chavan, S. S.; more...
    iScience (2021)

    Fulltext@MSK | Save
  • MAPK pathway activation represents a therapeutic vulnerability in ASCL1-driven SCLC
    Meeting Abstract

    Caeser, R.; Hulton, C.; Durani, V.; Costa, E.; Little, M.; Shah, N. S.; de Stanchina, E.; Poirier, J. T.; Rudin, C. M.; Sen, T.
    Cancer Research (2021)

    Fulltext@MSK | Save